Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Obstructive Lung Diseases

  Free Subscription


12.10.2026

1 Allergy
3 Am J Respir Crit Care Med
1 Ann Allergy Asthma Immunol
2 Arch Bronconeumol
2 Arch Dis Child
7 Chest
4 Eur Respir J
3 J Allergy Clin Immunol
1 J Investig Allergol Clin Immunol
5 Pediatr Allergy Immunol
2 Respir Med
3 Respir Res
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. GU W, Zhang X, Wang Y, Wang H, et al
    Epithelial Fucosylation Drives Airway Barrier Dysfunction and Allergic Inflammation via a FUT1 -CDH12 Axis.
    Allergy. 2026 Jun 17. doi: 10.1111/all.70413.
    PubMed         Abstract available


    Am J Respir Crit Care Med


  2. Correction: B107-14 Azd0292, a Novel Investigational Fc-engineered Humanized Monoclonal Antibody for Bronchiectasis With Chronic Pseudomonas Aeruginosa Colonization: Results From a Randomized Phase I Study in Healthy Adults.
    Am J Respir Crit Care Med. 2026 Oct 8:aamag475. doi: 10.1093.
    PubMed        

  3. REDDEL HK, Allan K, Bacharier LB, Bonini M, et al
    2026 Global Initiative for Asthma (GINA) Strategy Report: Executive Summary and Key Changes.
    Am J Respir Crit Care Med. 2026 Oct 8:aamag542. doi: 10.1093.
    PubMed         Abstract available

  4. CHALMERS JD
    Brensocatib is approved for adults and adolescents with bronchiectasis.
    Am J Respir Crit Care Med. 2026 Oct 7:aamag543. doi: 10.1093.
    PubMed        


    Ann Allergy Asthma Immunol

  5. MICHEALS K, Nguyen W, Alwesabi Y
    Explainable Machine Learning to Identify Clinical, Environmental, and Social Factors Associated with Diagnosed Pediatric Asthma.
    Ann Allergy Asthma Immunol. 2026 Oct 5:S1081-1206(26)01210.
    PubMed         Abstract available


    Arch Bronconeumol

  6. MARTINEZ MOLINA J, Garcia Garcia M, Munoz Montiel A, Giron Fernandez MV, et al
    Primary Ciliary Dyskinesia in Adults With Bronchiectasis: Diagnostic Yield of Genetic Testing and Clinical Characterisation.
    Arch Bronconeumol. 2026 Oct 9:S0300-2896(26)00358.
    PubMed        

  7. CALLE-RUBIO M, Miravitlles M
    Should Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency Genotype SZ Receive Augmentation Therapy? A Pro/Con Debate.
    Arch Bronconeumol. 2026 Oct 8:S0300-2896(26)00361.
    PubMed        


    Arch Dis Child

  8. HINE J, Bush A, De Simoni A, Griffiths C, et al
    Experiences of financial incentives to improve medication adherence for children and young people with asthma: a qualitative study.
    Arch Dis Child. 2026 Oct 9:archdischild-2026-331321.
    PubMed        

  9. HINE J, Bush A, De Simoni A, Griffiths C, et al
    Financial INcentives to improve Asthma (FINA): a pilot RCT to improve medication adherence for children and young people with asthma.
    Arch Dis Child. 2026 Oct 7:archdischild-2026-331320.
    PubMed         Abstract available


    Chest

  10. PU J, Hong S, He JQ
    Associations of Mucus Plug With Prognosis in COPD: A Systematic Review and Meta-Analysis.
    Chest. 2026;170:1074-1084.
    PubMed         Abstract available

  11. BOURDIN A, Beclin MF, Chanez P, Vachier I, et al
    Predicting Clinical Response to Benralizumab Using CT Imaging: Prognostic CT Air-Trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients (BenraliScan) Study.
    Chest. 2026;170:1024-1036.
    PubMed         Abstract available

  12. GARCIA AR, Vollmer I, Blanco I, San Jose Estepar R, et al
    Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease.
    Chest. 2026 May 27:S0012-3692(26)00704-X. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available

  13. KIM H, Chang Y, Yoon S, Ryu S, et al
    Chest Radiograph-Derived Age Acceleration as an Early Marker of Pulmonary Dysfunction in Middle-Aged Asian Adults.
    Chest. 2026;170:1174-1186.
    PubMed         Abstract available

  14. NAIR P, Zhang K, Lauks S, Kjarsgaard M, et al
    Sputum cellularity and health services utilization among patients with asthma and COPD.
    Chest. 2026 Oct 3:S0012-3692(26)06782-6. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available

  15. YANG F, Marshall DC, Howell I, Hinks TSC, et al
    Exacerbation trajectories in biologic-eligible severe asthma patients.
    Chest. 2026 Oct 5:S0012-3692(26)06789-9. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available


  16. Corrigendum to: Rivard R, Mailhot-Larouche A, Borg C, et al. Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleukin-5 Biologics. CHEST. 2026;170(1):E1-E4.
    Chest. 2026;170:1346.
    PubMed        


    Eur Respir J

  17. SALAZAR-PEREZ F, Sanz-Santiago V, de Mir-Messa I, Sardon Prado O, et al
    Home-based, remotely supervised, high-intensity interval training and cardiorespiratory fitness in children and adolescents with post-infectious bronchiolitis obliterans: a randomised controlled trial.
    Eur Respir J. 2026;68:2600265.
    PubMed         Abstract available

  18. BEECKMANS H, Kerckhof P, Geudens V, Vanluyten C, et al
    A transcriptomic atlas of chronic lung allograft dysfunction.
    Eur Respir J. 2026;68:2502380.
    PubMed         Abstract available

  19. POLVERINO F, Benam KH, Cloonan SM, Curtis JL, et al
    Preclinical models of COPD: a state of the art review.
    Eur Respir J. 2026;68:2600289.
    PubMed         Abstract available

  20. ASAKURA T, Choi H
    Nasal nitric oxide as a gateway, not a gatekeeper, to primary ciliary dyskinesia diagnosis in bronchiectasis.
    Eur Respir J. 2026;68:2601080.
    PubMed        


    J Allergy Clin Immunol

  21. LEUNG C, Yoo JW, Park HY, Bhutta H, et al
    Clinical and transcriptomic characterization of mixed granulocytic phenotype in chronic obstructive pulmonary disease.
    J Allergy Clin Immunol. 2026;158:982-993.
    PubMed         Abstract available

  22. LIANG J, An X, Yang Y, Wang N, et al
    HECT E3 ubiquitin ligase SMURF2 orchestrates FcepsilonRI-dependent mast cell activation and allergic responses.
    J Allergy Clin Immunol. 2026 Jun 12:S0091-6749(26)00412.
    PubMed         Abstract available

  23. ROCHMAN Y, Melamed JR, Klingler AM, Kotliar M, et al
    Antigen-Specific mRNA-LNP Therapy with mTOR Inhibition Promotes Treg Cells and Limits Allergy.
    J Allergy Clin Immunol. 2026 Jun 9:S0091-6749(26)00407.
    PubMed         Abstract available


    J Investig Allergol Clin Immunol

  24. BETANCOR D, Villalobos-Violan V, Antolin-Amerigo D, De Las Vecillas L, et al
    Tezepelumab in Severe Asthma in Routine Care: Real-World Effectiveness, Clinical Remission, and Biomarkers Predicting Response in a Multicenter Study.
    J Investig Allergol Clin Immunol. 2026 Oct 6:0. doi: 10.18176/jiaci.1198.
    PubMed        


    Pediatr Allergy Immunol

  25. TRIBHUVAN M, Phatke SN
    Comment on "Environmental risk factors for allergic rhinitis differ by income level: A global asthma network survey".
    Pediatr Allergy Immunol. 2026;37:e70502.
    PubMed        

  26. KYVSGAARD JN, Thorsen J, Jensen SK, Sultan T, et al
    Duration and severity of asthma-like episodes in young children vary by viral and bacterial triggers.
    Pediatr Allergy Immunol. 2026;37:e70499.
    PubMed         Abstract available

  27. ZHANG W, Li C, Wang X, Zheng F, et al
    Phenotypic patterns of allergic comorbidity and associated health outcomes in children and adolescents: A population-based latent class study.
    Pediatr Allergy Immunol. 2026;37:e70501.
    PubMed         Abstract available

  28. SOARES AV, Rodrigues M, Mendes FC, Moreira A, et al
    Evidence of eosinophilic airway inflammation in children with allergic rhinitis without asthma.
    Pediatr Allergy Immunol. 2026;37:e70519.
    PubMed        

  29. SKOV FR, Lovric M, Sultan T, Bonnelykke K, et al
    Early predictors of persistent childhood asthma and allergic rhinitis: A machine learning study using post-hoc explainability.
    Pediatr Allergy Immunol. 2026;37:e70498.
    PubMed         Abstract available


    Respir Med

  30. JABBAL S, Chaudhuri R, Smith A, Suter P, et al
    Scottish Airways Research Network (SARN) Delphi Consensus on pre-biologic assessment, clinical remission and post-remission management in severe asthma.
    Respir Med. 2026;263:109192.
    PubMed         Abstract available

  31. KAPLAN F
    Infant wheeze phenotypes do not establish a preventable trajectory to childhood asthma.
    Respir Med. 2026;263:109198.
    PubMed        


    Respir Res

  32. ABDO M, Skowasch D, Greulich T, Drick N, et al
    Real-world effectiveness of dupilumab in COPD: a German multicenter analysis.
    Respir Res. 2026;27:386.
    PubMed         Abstract available

  33. LI J, Liang L, Cai YS, Zhang D, et al
    Association of PM(2.5) chemical components with metabolome and peak expiratory flow in patients with stable COPD: a panel study.
    Respir Res. 2026;27:390.
    PubMed         Abstract available

  34. LIN M, Zhou J, Wang Y, Xu W, et al
    Protective role of lactate in allergic airway inflammation: mitigation of inflammatory injury, epithelial barrier integrity restoration, and gut-lung axis involvement.
    Respir Res. 2026;27:387.
    PubMed         Abstract available


    Thorax

  35. HATZIAGOROU E, Bush A
    Home spirometry in bronchiectasis: when does a measurement become medicine?
    Thorax. 2026 Oct 7:thorax-2026-225853. doi: 10.1136/thorax-2026-225853.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum